LCM
NAMSW icon

Laurion Capital Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Laurion Capital Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,666
Closed -$285K – 382
2025
Q3 		$285K Hold
16,666
– – ﹤0.01% 207
2025
Q2 		$133K Hold
16,666
– – ﹤0.01% 356
2025
Q1 		$150K Hold
16,666
– – ﹤0.01% 237
2024
Q4 		$237K Hold
16,666
– – ﹤0.01% 250
2024
Q3 		$117K Hold
16,666
– – ﹤0.01% 255
2024
Q2 		$145K Hold
16,666
– – ﹤0.01% 495
2024
Q1 		$184K Hold
16,666
– – ﹤0.01% 474
2023
Q4 		$52.2K Hold
16,666
– – ﹤0.01% 452
2023
Q3 		$31.7K Hold
16,666
– – ﹤0.01% 473
2023
Q2 		$34.8K Hold
16,666
– – ﹤0.01% 572
2023
Q1 		$30.7K Hold
16,666
– – ﹤0.01% 419
2022
Q4 		$13.3K Buy
+16,666
New +$13.7K ﹤0.01% 398

Other funds holding NAMSW

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Laurion Capital Management's NAMSW Position: Q4 2025 in Review

Laurion Capital Management sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q4 2025, closing a stake of 16,666 shares — an estimated $285K sold.

Laurion Capital Management first reported a position in NAMSW in Q4 2022 and held it in 12 quarters. The position peaked at $285K in Q3 2025. 9 funds tracked by Wall St. Rank hold NAMSW as of Q4 2025.

  • Laurion Capital Management reported no remaining NewAmsterdam Pharma Warrant position as of Q4 2025 after selling out during the quarter.
  • Laurion Capital Management sold 16,666 NewAmsterdam Pharma Warrant shares in Q4 2025, an estimated $285K.
  • Laurion Capital Management first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 12 quarters.
  • Laurion Capital Management's NewAmsterdam Pharma Warrant position peaked at $285K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q4 2025.

Based on Laurion Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.